Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 12
Submit an article Journal homepage
386
Views
20
CrossRef citations to date
0
Altmetric
Brief Report

Low doses of transdermal fentanyl in opioid-naive patients with cancer pain

Sebastiano Mercadante Anaesthesia & Intensive Care Unit, and Pain Relief & Palliative Care Unit, La Maddalena Cancer Centre, Palermo, Italy; Anaesthesiology and Intensive Care, Master of Palliative Medicine, University of Palermo, Palermo, ItalyCorrespondence[email protected]
,
Gianpiero Porzio L’Aquila per la Vita – Home Care Service, L’Aquila, Italy
,
Patrizia Ferrera Anaesthesia & Intensive Care Unit, and Pain Relief & Palliative Care Unit, La Maddalena Cancer Centre, Palermo, Italy
,
Federica Aielli L’Aquila per la Vita – Home Care Service, L’Aquila, Italy
,
Claudio Adile Anaesthesia & Intensive Care Unit, and Pain Relief & Palliative Care Unit, La Maddalena Cancer Centre, Palermo, Italy
&
Corrado Ficorella Department of Oncology – University of L’Aquila
Pages 2765-2768 | Accepted 13 Oct 2010, Published online: 01 Nov 2010

References

  • World Health Organization. Cancer Pain Relief and Palliative Care. Geneva: WHO, 1990
  • Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. JAMA 1995;274:1870-3
  • Mercadante S. Opioid titration in cancer pain: a critical review. Eur J Pain 2007;11:823-30
  • van Seventer R, Smit JM, Schipper RM, et al. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr Med Res Opin 2003;19:457-69
  • Vielvoye-Kerlmeer A, Mattern C, Uitendaal M. Transdermal fentanyl in opioid-naive cancer patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine. J Pain Symptom Manage 2000;19:185-92
  • Tawkfik MO, Bryuzgin V, Kourteva G. Use of transdermal without prior opioid stabilization in patients with cancer pain. Curr Med Res Opin 2004;20:259-67
  • Maltoni M, Scarpi E, Modonesi C, et al. A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer 2005;13:888-94
  • Marinangeli F, Ciccozzi A, Leonardis M, et al. Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage 2004;27:409-16
  • Koizumi W, Toma H, Watanabe K. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naïve cancer pain patients, starting with 5 mg tablets. Jpn J Clin Oncol 2004;34:608-14
  • Mercadante S, Porzio G, Ferrera P, et al. Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage 2006;31:242-7
  • De Conno F, Ripamonti C, Fagnoni E, et al. MERITO Study Group. The MERITO study: a multicenter trial of the analgesic effect and tolerability of normal-release oral morphine during ‘titration phase’ in patients with cancer pain. Palliat Med 2008;22:214-21
  • Mercadante S, Porzio G, Ferrera P, et al. Low doses of transdermal buprenorphine in opioid-naive cancer patients with pain. Clin Ther 2009;25:1517-28
  • Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer 1990;62:695-9
  • Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 2008;12:1040-6
  • Mystakidou K. Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II & III transfers. J Pain 2004;5:119-32
  • Mystakidou K, Befon S, Tsilika E, et al. Use of fentanyl TTS as a single opioid for cancer pain relief: a safety and efficacy trial in patients naive to mild of strong opioids. Oncology 2002;62:9-16
  • Mystakidou K, Tsilika E, Kouloulias V. Long-term cancer pain management in morphine pre-treated and opioid naive patients with transdermal fentanyl. Int J Cancer 2003;107:486-92
  • Mystakidou K, Befon S, Kouskouni E, et al. From codeine to transdermal for cancer pain control: a safety and efficacy clinical trial. Anticancer Res 2001;21:2225-30
  • Janssen, LP. Important drug warning. Available at: http://www.fda.gov/medwatch/SAFETY/2005/duragesic_ddl-pdf
  • Otis J, Rothman M. A phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain. Curr Med Res Opin 2006;22:1493-501

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.